![Dorman Followwill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 507 $ al 30/06/2026
Dorman Followwill is currently an Independent Director at Semnur Pharmaceuticals, Inc. since 2025, an Independent Director at Scilex Holding Co. since 2022, and a Senior Partner-Transformational Health at Frost & Sullivan, Inc. since 2016.
Former positions include Independent Director at Scilex, Inc. in 2022 and Independent Director at Sorrento Therapeutics, Inc. from 2017 to 2020.
Education includes an undergraduate degree from Stanford University conferred in 1985.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/04/2026 | 65 ( 0 % ) | 507 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SCILEX HOLDING COMPANY | Director/Miembro de la Junta | 10/11/2022 |
Frost & Sullivan, Inc.
 Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Corporate Officer/Principal | 01/01/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Director/Miembro de la Junta | 01/11/2022 |
| SORRENTO THERAPEUTICS, INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frost & Sullivan, Inc.
Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Finance |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
